Lauri Markkanen with a dunk vs the Los Angeles Lakers
Lauri Markkanen (Chicago Bulls) with a dunk vs the Los Angeles Lakers, 01/23/2021
The "6-Hour Virtual Seminar on Designing Stark Compliant Physician Compensation Models" webinar has been added to ResearchAndMarkets.com's offering.
Israel’s defense minister says his country has drawn up plans to strike Iranian targets if Tehran shows signs of nuclear escalation. Benny Gantz told Fox News that Israel is still working on its plans, but “we have them in our hands of course.” The remarks come as President Joe Biden’s administration considers re-joining the 2015 Iran nuclear deal to limit Iran's nuclear program, with some changes to toughen curbs on Tehran's activities.
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Probiotic Cosmetic Products Market By Distribution Channel (Hypermarket & Supermarket, Pharmacy & Drug Store, E-commerce and other Distribution Channels), By Product (Skin care and Hair Care), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Probiotic Cosmetic Products Market size is expected to reach $400 Million by 2026, rising at a market growth of 11% CAGR during the forecast period. Probiotic skincare cosmetic products are considered as beauty products that help in increasing the healing benefits of good microorganisms present in our skin. Such products are also in high demand as they control the natural immune response of the skin and create better skin immunity and resilience. The market of probiotic skincare cosmetic products is witnessing a rising growth graph as these products are really beneficial in maintaining bright skin and aid in preventing issues related to skin.For attaining a competitive advantage over others, the people in this market are always in the pursuit of developing products that are profitable and have a positive impact on consumers. Manufacturers also strive to produce cosmetic products mixed with probiotics and other products to improve the quality of cosmetic products.The increasing adoption of probiotics as dietary supplement, probiotics witness a massive demand in the cosmetics category, hence boosting the growth of the market. These cosmetic products are beneficial and suitable to all skin types and can assist in reducing problems related to eczema, chronic inflammation, rosacea, and acne.The industry has been severely impacted by the global COVID-19 pandemic. Various governments have implemented different measures to contain the spread of virus such as Stay-home policy, lockdown measures, and store closures which caused a severe decline in sales. During the pandemic, one of the major observations is that the sentiment of consumers has shifted more toward basic skincare routines and necessities, thus reducing the demand for the probiotic products. Also, the present situation has encouraged customers to step back and choose mass skincare products, which are significantly cheaper and extensively available across all distribution channels.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Estee Lauder Companies, Inc., L'Oreal Group, Unilever PLC, The Clorox Company, Health and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare), Esse Skincare, Tula Life, Inc., Eminence Organic Skin Care, Glowbiotics, Inc., and LaFlore Probiotic Skincare. Key Topics Covered: Chapter 1. Market Scope & Methodology1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Probiotic Cosmetic Products Market, by Distribution Channel1.4.2 Global Probiotic Cosmetic Products Market, by Product1.4.3 Global Probiotic Cosmetic Products Market, by Geography1.5 Methodology for the researchChapter 2. Market Overview2.1 Introduction2.1.1 Overview2.1.2 Market composition and scenario2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market RestraintsChapter 3. Global Probiotic Cosmetic Products Market by Distribution Channel3.1 Global Hypermarket & Supermarket Market by Region3.2 Global Pharmacy & Drug Store Market by Region3.3 Global E-commerce Market by Region3.4 Global Other Distribution Channels Market by RegionChapter 4. Global Probiotic Cosmetic Products Market by Product4.1 Global Skin care Market by Region4.2 Global Hair care Market by RegionChapter 5. Global Probiotic Cosmetic Products Market by RegionChapter 6. Company Profiles6.1 Company Overview6.2 Financial Analysis6.3 Regional Analysis6.4 Research & Development Expense6.5 Recent strategies and developments:6.5.1 Partnerships, Collaborations, and Agreements6.5.2 Product Launches and Product Expansions Estee Lauder Companies, Inc.L'Oreal GroupUnilever PLCThe Clorox CompanyHealth and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare)Esse SkincareTula Life, Inc.Eminence Organic Skin CareGlowbiotics, Inc.LaFlore Probiotic Skincare For more information about this report visit https://www.researchandmarkets.com/r/wr9vgx CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
(Bloomberg) -- London Stock Exchange Group Plc said it will spend more on its integration with Refinitiv this year, disappointing analysts and sending its shares falling. Capital expenditure is expected to be about 850 million pounds ($1.2 billion) in 2021, with 150 million pounds of associated operating costs, according to a statement Friday.That overshadowed the company’s confident outlook as it increased its full-year dividend by 7% for 2020. Shares dropped as much as 6.4% in London.Revenue rose to 2.1 billion pounds ($2.9 billion) in 2020 and the company proposed a final dividend of 51.7 pence a share. The group said its recently completed acquisition of Refinitiv left it well-positioned to navigate the challenges of the pandemic and Brexit.“LSEG is now truly global with a significant presence in North America, Europe, Asia and emerging markets,” Chief Executive Officer David Schwimmer said in the statement. The group “is well positioned for long-term sustainable growth.”The stock exchange completed its $27 billion purchase of Refinitiv earlier this year, kicking off a new era where the majority of its revenues come from data. Schwimmer said in a call with journalists that he expects the combination to result in some job cuts and a reduction in some of its real estate footprint.The combined company will generate about 70% of revenues from data, up from 40%, according to Bloomberg Intelligence. The parent company of Bloomberg News competes with Refinitiv to provide financial news, data and information.Schwimmer said LSEG was well-positioned to handle continuing uncertainties around how Brexit might impact the City of London.LSEG’s clearing unit remains a critical element of the European Union’s financial infrastructure even after the U.K. left the bloc. EU politicians have been vocal in demanding that companies shift euro clearing out of London and into the 27-nation bloc. They have achieved some success, with Eurex in Frankfurt increasing its share of euro clearing.Clearing VolumesSo far, though, Schwimmer said the company has seen “no discernible change” in its LCH clearing business, which can continue to service clients in the European Union through June 2022 under the bloc’s temporary rules.“Volumes continue to be very strong and if anything growing,” Schwimmer said in an interview with Bloomberg Television Friday.While London lost its crown to Amsterdam this year as the top place in Europe to buy and sell stock, the shift has had little impact on the group itself, with trades previously done on the company’s U.K. venues largely moving over to its Dutch platform.Schwimmer also welcomed proposals from a review of London’s listings rules, saying recommendations unveiled this week including on special purpose acquisition companies, or SPACs, should be adopted quickly to help London maintain its prime position.“No question, London remains one of world’s leading financial capitals,” Schwimmer said.(Updates with details throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Here are some of the wonderful actors you seldom see in public with their significant others.
The move is likely to further sour relations between Australia and China, which are already at the lowest point in decades.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree William Hill plc(GB0031698896)(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4 March 2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 10p Ordinary Shares Interests Short positions Number % Number %(1) Relevant securities owned and/or controlled: 15,253,965* 1.45% (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 15,253,965 1.45% *Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 159,718 shares. All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unitOrdinary shares Sale 189,562 GBP 2.7090 (b) Cash-settled derivative transactions Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5 March 2021 Contact name: Thomas HoneTelephone number: 020 3033 3419 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
The 24-year-old midfielder made his first start in the Premier League for six months
German Health Minister Jens Spahn said on Friday that drug manufacturers must honour vaccine supply contracts to Europe, but said Germany had not yet had any reason to stop shipments of shots produced domestically to other countries. Spahn told a weekly news conference he had not yet been able to speak to his Italian counterpart about a decision by Italy to block a shipment of AstraZeneca's coronavirus vaccine to Australia.
The "Spain Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook): Spend Analysis by Digital/e-Gift Card, Retail & Corporate Consumers, Top Retailers, Distribution Channel, Occasions, and Demographics - Jan 2021 Update" report has been added to ResearchAndMarkets.com's offering.
YouTube terminated channels of broadcasters Myawaddy Media, MRTV, WD Online Broadcasting, MWD Variety and MWD Myanmar.
There are far too many parties interested in ensuring that the ceasefire fails. Meanwhile, trust-but-verify holds.
Mike Ashley's group says the package would make it "nearly impossible" to take on ex-Debenhams stores.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Arrow Global Group plc(GB00BDGTXM47)(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4 March 2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 1p Ordinary Shares Interests Short positions Number % Number %(1) Relevant securities owned and/or controlled: 3,242,805* 1.83% (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 3,242,805 1.83% *Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 67,304 shares. All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unitOrdinary shares Sale 3,771 GBP 2.6721 (b) Cash-settled derivative transactions Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5 March 2021 Contact name: Thomas HoneTelephone number: 020 3033 3419 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Northern Ireland First Minister Arlene Foster said the UK had to take action.
BRUSSELS — Australia is seeking assurances from the European Union's executive arm that future shipments of vaccines will not be blocked, after Italy banned a large export of the AstraZeneca coronavirus shots. The shipment to Australia of more than a quarter-million doses was blocked from leaving the 27-nation bloc — the first use of an export control system instituted by the EU to make sure big pharma companies respect their EU contracts. The ban was requested by Italian authorities and approved by the EU in a move that frustrated the Australian government. “The world is in uncharted territory at present, it’s unsurprising that some countries would tear up the rule book," finance minister Simon Birmingham told Sky News Australia on Friday. Birmingham ackhnowledged, however, that Australia received 300,000 doses of the AstraZeneca vaccine last week, and “that will see our current distribution plan work." Australia’s immunization program began last month and the government expects the vaccine will be made available to anyone who wants it by October. The country has secured 53.8 million doses of the vaccine made by AstraZeneca and Oxford University, 50 million of which will be made in Australia in a partnership with Melbourne-based biopharmaceutical company CSL. “We are obviously disappointed and frustrated by this decision," Birmingham said. “It is very much a reminder of the desperation that exists in other parts of the world, compared with the very good position we found ourselves in here in Australia." According to Australian media, Health Minister Greg Hunt has asked the European Commission to review the Italian decision. The shipment ban was the latest development in the dispute between the EU and AstraZeneca over delays in deliveries. Faced with shortages of doses during the early stages of the vaccine campaign that started in late December in the bloc, the EU issued an export control system for COVID-19 vaccines in late January, forcing companies to respect their contractual obligations to the bloc before commercial exports can be approved. The EU has been specifically angry with AstraZeneca because it is delivering far fewer doses to the bloc than it had promised. Of the initial order for 80 million doses to the EU in the first quarter, the company will be struggling to deliver half that quantity. The EU thought it had made excellent preparations for the rollout of vaccines. With its 450 million people, the EU has signed deals for six different vaccines. In total, it has ordered up to 400 million doses of the AstraZeneca vaccine and sealed agreements with other companies for more than 2 billion shots. But only 33 million doses have been given so far, and only 11 million Europeans have been fully vaccinated. Despite the current difficulties, the EU's goal remains to vaccinate 70% of the adult population in the bloc by the end of summer. ___ Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak The Associated Press
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "U.S. Faster Payments Forecast: The Volume Begins to Build" report has been added to ResearchAndMarkets.com's offering. The pace of real-time and faster payments adoption accelerated in the U.S. during 2020 as explored in new research, U.S. Faster Payments Forecast: The Volume Begins to Build. Solutions such as debit push payments, The Clearing House RTP network, Same Day ACH, and Zelle all experienced strong double-digit and even triple-digit growth in certain use cases. Gains were in part due to the unique environment created by the global pandemic which values fast digital payment types, plus the simple fact that financial institutions and fintechs alike continued to integrate and launch new payment options for customers and members. "More financial institutions completed technical integrations with faster and real-time networks, not only driving transactions from their customers and members for these products, but also beginning to drive internal efficiencies leveraging the new payment rails for account transfers, vendor payments, or payments from clients for loans and credit cards. Faster and real-time payments came to the rescue during the global pandemic, providing more convenient P2P transactions and opportunities including same day settlement for smaller retailers who appreciated receiving their merchant settlement more quickly," comments Sarah Grotta, Director, Debit and Alternative Products Advisory Service. Highlights of the report include: A view into the current state of progression for The Clearing House RTP system, Early Warning's Zelle network, the global debit networks' push payments and Same Day ACHA forecast for dollar volumes processed for each of the networksDiscussion of some of the misnomers and myths circulating about faster and real-time paymentsCurrent use cases where faster payments are succeedingWhere the next wave of faster payments growth is likely to emerge Key Topics Covered: Executive Summary Introduction A DefinitionDispelling Some Myths Where the Market is Growing Now on Available Networks FedNow Debit Card Network Push Payments RTPSame Day ACHZelle Conclusion: Three Key Drivers that Will Power the Next Wave of Growth References Related ResearchEndnotes For more information about this report visit https://www.researchandmarkets.com/r/exvv9z CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The girl's family was determined to lodge a complaint against the four youths but the village Panchayat gave the family an alternative proposal of getting her married to one of these youths.
Claressa Shields is in confident mood as she looks to make more boxing history on Friday night. The highly-decorated two-time Olympic gold medalist battles women’s IBF light-middleweight title-holder Marie-Eve Dicaire of Canada in her hometown of Flint, Michigan. Having previously achieved the feat at middleweight, Shields is now seeking to become an undisputed world champion in a second weight division as she also puts her WBC and WBO belts on the line as well as competing for the vacant WBA (Super) and The Ring titles.
Northern Ireland's first minister said the European Union's promise of legal action over the UK extending grace periods for trade showed its priority was protecting the trading bloc, not the Belfast peace agreement. "What they're only interested in is protecting their bloc, they're not interested, as they claim to be, in protecting the Belfast agreement," Arlene Foster told BBC radio on Friday. The European Union said on Wednesday it would take legal action after the British government unilaterally extended a grace period for checks on food imports to Northern Ireland, a move Brussels said violated the terms of Britain's divorce deal.